NCT07143669View on ClinicalTrials.gov

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Not yet recruitingOBSERVATIONAL

Enrollment

450

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

October 31, 2028

Conditions

Clonal Mast Cell DiseaseKIT D816V MutationSuspected KITD816V Mutated Clonal Mast Cell Disease

Interventions

OTHER

Screening

After providing informed consent and relevant medical history data, samples will be collected from participants with suspected clonal mast cell disease.